Detalhe da pesquisa
1.
SARS-CoV-2 3CL-protease inhibitors derived from ML300: investigation of P1 and replacements of the 1,2,3-benzotriazole.
Res Sq
; 2023 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37214977
2.
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro).
J Med Chem
; 65(4): 2880-2904, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34347470